Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Phenex Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013935
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechnology, veterinary medicine and food companies. It carries out research and development programs in the areas of liver and gastrointestinal diseases, chronic inflammatory diseases, diabetes, dermatology and cancer. The company develops NR resource assays for nuclear receptors in various formats. It operates in Ludwigshafen and Heidelberg. Phenex is headquartered in Ludwigshafen, Germany.

Phenex Pharmaceuticals AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Licensing Agreements 11
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Asset Transactions 12
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG – Key Competitors 14
Phenex Pharmaceuticals AG – Key Employees 15
Phenex Pharmaceuticals AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Key Facts 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenex Pharmaceuticals AG, Deals By Therapy Area, 2011 to YTD 2017 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG, Key Competitors 14
Phenex Pharmaceuticals AG, Key Employees 15
Phenex Pharmaceuticals AG, Other Locations 16

★海外企業調査レポート[Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Prometheus Energy Group Inc:石油・ガス:M&Aディール及び事業提携情報
    Summary Prometheus Energy Group Inc (Prometheus) is an oil and gas company that supplies liquefied natural gas. The company offers services such as LNG conversion solutions, LNG storage and supply, turnkey fuel solutions, logistics and distribution, and storage, re-gas and field service. It offers t …
  • Aohata Corporation:企業の戦略・SWOT・財務情報
    Aohata Corporation - Strategy, SWOT and Corporate Finance Report Summary Aohata Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Bionik Laboratories Corp (BNKL):企業の財務・戦略的SWOT分析
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company offers rehabilitation technology that senses patient movements and limitations. It provides lower body e …
  • Energiekontor AG (EKT):企業の財務・戦略的SWOT分析
    Summary Energiekontor AG (Energiekontor) is a renewable energy company that develops and operates offshore wind farms. The company operates in the field of project development and sales, power generation in group-owned wind farms, and operation development services. Its services include construction …
  • NEC Networks & System Integration Corp (1973):企業の財務・戦略的SWOT分析
    NEC Networks & System Integration Corp (1973) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Decas Cranberry Products, Inc.:企業の戦略・SWOT・財務情報
    Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Decas Cranberry Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ellex Medical Lasers Limited (ELX)-医療機器分野:企業M&A・提携分析
    Summary Ellex Medical Lasers Limited (Ellex) is a medical technology company that develops, manufactures, sells and distributes medical equipment for use in ophthalmic procedures. The company also offers a range of third-party medical devices and technologies. Ellex’s product portfolio includes lase …
  • Zymeworks Inc (ZYME):製薬・医療:M&Aディール及び事業提携情報
    Summary Zymeworks Inc (Zymeworks) is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of biotherapeutics for the treatment of cancer, autoimmune and inflammatory diseases. Its pipeline products include ZW25 and ZW49, novel bispecific antibodies …
  • MeVis Medical Solutions AG (M3V):医療機器:M&Aディール及び事業提携情報
    Summary MeVis Medical Solutions AG (MMS AG), a subsidiary of Varian Medical Systems, Inc., is a medical technology company. It develops and markets software to analyze and evaluate image data to medical device equipment manufacturers and providers of medical IT platforms. The company’s software solu …
  • Texas A&M University-製薬・医療分野:企業M&A・提携分析
    Summary Texas A&M University (TAMU) is a research based university that offers educational and research services. The university provides undergraduate, graduate and professional courses to its students. It consists of various colleges and departments such as College of Agriculture and Life Sciences …
  • Consumers Energy Co (CMS PR B):電力:M&Aディール及び事業提携情報
    Summary Consumers Energy Co (Consumers), formerly Consumers Power, is an electric and natural gas utility. The company generates purchases, transmits, distributes, and sells electricity. It also carries out the purchase, transmission, storage, distribution, and sale of natural gas. It generates elec …
  • Catholic Medical Center:企業の戦略的SWOT分析
    Catholic Medical Center - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Forge Energy LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Forge Energy LLC (Forge Energy) is an independent oil and gas exploration and production company that acquires, explores, operates, manages, produces and develops natural oil and gas properties. The company offers services such as consolidation, acquisition, leasing, and exploitation of matu …
  • Medical Developments International Ltd (MVP):企業の財務・戦略的SWOT分析
    Summary Medical Developments International Ltd (MDI) is a healthcare company that develops, manufactures and markets pain relief and respiratory medicine. The company provides products such as penthrox, asthma and COPD, medical devices and veterinary products. It offers asthma and COPD products whic …
  • TECSYS Inc. (TCS):企業の財務・戦略的SWOT分析
    TECSYS Inc. (TCS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Eversource Energy (ES):電力:M&Aディール及び事業提携情報
    Summary Eversource Energy (Eversource) is a utility holding company, which operates energy delivery business through its subsidiaries. It transmits and distributes electricity and natural gas. The company sources electricity from its facilities, long-term power supply agreements, and competitive ene …
  • ISA Pharmaceuticals BV:製薬・医療:M&Aディール及び事業提携情報
    Summary ISA Pharmaceuticals BV (ISA Pharmaceuticals) is a developer of synthetic therapeutic vaccines for the treatment of cancer and persistent viral infections. The company’s pipeline products include ISA101, an immunotherapeutic vaccine for cervical cancer; MyISA, a personalized immunotherapy bas …
  • US Physical Therapy Inc (USPH):企業の財務・戦略的SWOT分析
    US Physical Therapy Inc (USPH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • St. Jude Medical, Inc.:企業のM&A・事業提携・投資動向
    St. Jude Medical, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's St. Jude Medical, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆